News | December 14, 2022
Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility
The investment will enable the company to enter European markets as well as enhance margins in current markets
The investment will enable the company to enter European markets as well as enhance margins in current markets
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
Shandong Meditech Medical Technology is a manufacturer of onsite oxygen solutions for the healthcare market.
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
Subscribe To Our Newsletter & Stay Updated
